Stay updated on GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.

Latest updates to the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page now shows 'No longer looking for participants', signaling that recruitment has closed. It indicates the study is not accepting new participants.SummaryDifference0.4%

- Check13 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's versioning rather than substantive content changes.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s revision label was updated from v3.5.3 to v3.5.4, indicating a new software build. This change does not modify study information or user-facing features beyond the version badge.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page has been updated to revision v3.5.3, replacing v3.5.2, indicating a minor maintenance release for the page. This change does not alter the study content or key information presented on the page.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2; v3.5.2 was added and v3.5.0 removed. This updates the page version without changing the study details or user-facing content.SummaryDifference0.1%

- Check85 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page.SummaryDifference0.1%

Stay in the know with updates to GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.